Healthcare resource use and costs associated with the misdiagnosis of migraine
Authors:
Open Access
- 28 August 2024
- journal article
- research article
- Published by Wiley in Headache: The Journal of Head and Face Pain
- Vol. 65 (1) , 35-44
Abstract
Objective: To compare healthcare resource utilization and healthcare costs in patients with migraine with or without a history of misdiagnosis.Background: Despite the high prevalence of migraine, migraine is commonly misdiagnosed. The healthcare resource use and cost burden of a misdiagnosis is unknown.Methods: This retrospective cohort study identified adults with an incident migraine diagnosis from the Merative™ Marketscan® Commercial and Medicare Supplemental Databases between June 2018 and 2019. Patients with a diagnosis of commonly considered misdiagnoses (headache, sinusitis, or cervical pain) before their migraine diagnosis were classified as the “misdiagnosed cohort.” Patients in the misdiagnosed cohort were potentially misdiagnosed, then eventually received a correct diagnosis. Patients without a history of commonly considered misdiagnoses prior to their migraine diagnosis were classified as the “correctly diagnosed cohort.” Healthcare resource utilization and healthcare costs were assessed in the period before migraine diagnosis and compared between the cohorts. Outcomes were reported as per patient per month and compared with incidence rate ratios.Results: A total of 29,147 patients comprised the correctly diagnosed cohort and 3841 patients comprised the misdiagnosed cohort and met the inclusion criteria. Patients in the misdiagnosed cohort had statistically significantly higher rates of inpatient admissions (0.02 vs. 0.01, incidence rate ratio [IRR] 1.61, 95% confidence interval [CI] 1.47–1.74), emergency department visits (0.10 vs. 0.05; IRR 1.89, 95% CI 1.79–1.99), neurologist visits (0.12 vs. 0.02; IRR 5.95, 95% CI 5.40–6.57), non‐neurologist outpatient visits (2.64 vs. 1.58; IRR 1.67, 95% CI 1.62–1.72) and prescription fills (2.82 vs. 1.84; IRR 1.53, 95% CI 1.48–1.58) compared to correctly diagnosed patients. Misdiagnosed patients had statistically significantly higher rates of healthcare cost accrual for inpatient admissions ($1362 vs. $518; IRR 2.62, 95% CI 2.50–2.75), emergency department visits ($222 vs. $98; IRR 2.27, 95% CI 2.18–2.36), neurologist visits ($42 vs. $9; IRR 4.39, 95% CI 4.00–4.79), non‐neurologist outpatient visits ($1327 vs. $641; IRR 2.07, 95% CI 1.91–2.24), and prescription fills ($305 vs. $215; IRR 1.41, 95% CI 1.18–1.70) compared to correctly diagnosed patients.Conclusion: Patients with migraine who have a history of misdiagnoses have higher rates of healthcare resource utilization and cost accrual versus those without such history.Keywords
Funding Information
- AbbVie
This publication has 31 references indexed in Scilit:
- Practical Insights on the Identification and Management of Patients with Chronic MigrainePain and Therapy, 2022
- Survey of Pain Medicine Specialists' Familiarity with Migraine ManagementPain Medicine, 2021
- Diagnosis and management of migraine in ten stepsNature Reviews Neurology, 2021
- Real-world migraine-related healthcare resource utilization and costs associated with improved vs. worsened/stable migraine: a panel-based chart review in France, Germany, Italy, and SpainJournal of Medical Economics, 2021
- Migraine and Tension-Type HeadacheMedical Clinics of North America, 2019
- The role of instrumental examinations in delayed migraine diagnosisNeurological Sciences, 2011
- Coding Algorithms for Defining Comorbidities in ICD-9-CM and ICD-10 Administrative DataMedical Care, 2005
- Center of Excellence for Headache Care: Group Model at Kaiser PermanenteHeadache: The Journal of Head and Face Pain, 2003
- Migraine Diagnosis and Treatment: Results From the American Migraine Study IIHeadache: The Journal of Head and Face Pain, 2001
- Primary Headache Care Delivery by Nonspecialists in BrazilCephalalgia, 1999